Pharmacokinetic disposition of intravenous and oral pentoxifylline in horses
- 1 March 1993
- journal article
- Published by Wiley in Journal of Veterinary Pharmacology and Therapeutics
- Vol. 16 (1) , 23-31
- https://doi.org/10.1111/j.1365-2885.1993.tb00285.x
Abstract
The pharmacokinetics of pentoxifylline (P) and its alcohol metabolite I (MI) were determined after administration of intravenous pentoxifylline, sustained release pentoxifylline tablets (Trental), and crushed pentoxifylline tablets in corn syrup, to five healthy adult horses. Pharmacokinetics were evaluated in a model-independent manner. After intravenous administration, pentoxifylline was rapidly eliminated (mean residence time 1.09 +/- 0.67 h), had a large steady-state volume of distribution (2.81 +/- 1.16 l/kg), and high clearance (3.06 +/- 1.05 l/kg/h). Oral absorption of pentoxifylline from both dose forms varied considerably between individuals. Times to peak concentration ranged from 1-10 h for either dose form. There was no difference in relative bioavailability (F') between whole (0.98 +/- 0.30) and crushed Trental tablets. Ratios between areas under the curve (AUC) for pentoxifylline and MI were different following administration of oral versus intravenous doses. This finding suggests that route of administration may affect the metabolic profile of pentoxifylline. Given the extreme differences in absorption characteristics between individuals in this study, recommendations are not made as to appropriate dose, dose interval, or dose form for administration of pentoxifylline to horses.Keywords
This publication has 13 references indexed in Scilit:
- Pentoxifylline improves survival following hemorrhagic shockCritical Care Medicine, 1989
- Pentoxifylline Decreases Endotoxin-induced Pulmonary Neutrophil Sequestration and Extravascular Protein Accumulation in the DogAmerican Review of Respiratory Disease, 1988
- Determination of pentoxifylline and a major metabolite, 3,7-dimethyl-1-(5′-hydroxyhexyl)xanthine, by high-performance liqid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1986
- Haemorrheological improvement by pentoxifylline in patients with peripheral arterial occlusive diseaseCurrent Medical Research and Opinion, 1986
- Pharmacokinetics of Orally Administered Pentoxifylline in HumansJournal of Pharmaceutical Sciences, 1986
- Clinical investigation of the effects of pentoxifylline in patients with severe peripheral occlusive vascular diseaseCurrent Medical Research and Opinion, 1985
- Pentoxifylline efficacy in the treatment of intermittent claudication: Multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patientsAmerican Heart Journal, 1982
- Factors affecting absorption of non-steroidal anti-inflammatory agents in the horseVeterinary Record, 1982
- Influence of Food on the Bioavailability of Trental® (Pentoxifylline) in ManDrug Development and Industrial Pharmacy, 1981
- IMPAIRED RED CELL DEFORMABILITY IN PERIPHERAL VASCULAR DISEASEThe Lancet, 1976